;Donanemab’ drug approved for treatment of Alzheimer’s disease by FDA
The FDA approved on Tuesday the donanemab drug for treatment of Alzheimer’s disease. The drug contains an antibody that aims to slow the progression of the incurable Alzheimer’s disease. It operates by eliminating the buildup of amyloid protein plaque in the brain. According to the manufacturer, Lilly, the drug will be marketed under the […]
Continue Reading